Dr Reddy's Laboratories has introduced a bioequivalent generic version of Geodon, Ziprasidone Hydrochloride Capsules, in the US.
Subscribe to our email newsletter
The company’s Ziprasidone Hydrochloride Capsules in 20mg, 40mg, 60mg and 80mg strengths are available in 60 count bottle size.
The United States Food & Drug Administration (USFDA) approved Dr Reddy’s ANDA for Ziprasidone Hydrochloride Capsules.
The Geodon brand had US sales of approximately $1.34bn for the recent twelve months ending December 2011 according to IMS Health.
Dr Reddy’s offers a portfolio of products and services including APls, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.